The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges

GR Tundo, D Sbardella, AM Santoro, A Coletta… - Pharmacology & …, 2020 - Elsevier
Abstract Ubiquitin Proteasome System (UPS) is an adaptable and finely tuned system that
sustains proteostasis network under a large variety of physiopathological conditions. Its …

Proteasome activation as a new therapeutic approach to target proteotoxic disorders

E Njomen, JJ Tepe - Journal of medicinal chemistry, 2019 - ACS Publications
Proteasomes are multienzyme complexes that maintain protein homeostasis (proteostasis)
and important cellular functions through the degradation of misfolded, redundant, and …

Genetic and pharmacologic proteasome augmentation ameliorates Alzheimer's-like pathology in mouse and fly APP overexpression models

ES Chocron, E Munkácsy, HS Kim, P Karpowicz… - Science …, 2022 - science.org
The proteasome has key roles in neuronal proteostasis, including the removal of misfolded
and oxidized proteins, presynaptic protein turnover, and synaptic efficacy and plasticity …

A protein–protein interaction map reveals that the Coxiella burnetii effector CirB inhibits host proteasome activity

M Fu, Y Liu, G Wang, P Wang, J Zhang, C Chen… - PLoS …, 2022 - journals.plos.org
Coxiella burnetii is the etiological agent of the zoonotic disease Q fever, which is featured by
its ability to replicate in acid vacuoles resembling the lysosomal network. One key virulence …

Advances in proteasome enhancement by small molecules

DE George, JJ Tepe - Biomolecules, 2021 - mdpi.com
The proteasome system is a large and complex molecular machinery responsible for the
degradation of misfolded, damaged, and redundant cellular proteins. When proteasome …

Widespread microbial utilization of ribosomal β-amino acid-containing peptides and proteins

TA Scott, M Verest, J Farnung, CC Forneris… - Chem, 2022 - cell.com
Summary β-Amino residues are regarded as extremely rare features among ribosomal
products. They can be installed by a remarkable non-canonical enzymatic splicing process …

The emerging roles of E3 ligases and DUBs in neurodegenerative diseases

N Liu, MM Lin, Y Wang - Molecular Neurobiology, 2023 - Springer
Despite annual increases in the incidence and prevalence of neurodegenerative diseases,
there is a lack of effective treatment strategies. An increasing number of E3 ubiquitin ligases …

Exploring the proteasome system: A novel concept of proteasome inhibition and regulation

X Wang, T Meul, S Meiners - Pharmacology & Therapeutics, 2020 - Elsevier
The proteasome is a well-identified therapeutic target for cancer treatment. It acts as the
main protein degradation system in the cell and degrades key mediators of cell growth …

Ubiquitin biology in neurodegenerative disorders: From impairment to therapeutic strategies

D Kumar, RK Ambasta, P Kumar - Ageing Research Reviews, 2020 - Elsevier
The abnormal accumulation of neurotoxic proteins is the typical hallmark of various age-
related neurodegenerative disorders (NDDs), including Alzheimer's disease, Parkinson's …

Proteasome activation to combat proteotoxicity

CL Jones, JJ Tepe - Molecules, 2019 - mdpi.com
Loss of proteome fidelity leads to the accumulation of non-native protein aggregates and
oxidatively damaged species: hallmarks of an aged cell. These misfolded and aggregated …